As one of Connecticut's giant pharma companies announced it will exit the state for good, advocates for the biotech sector said it's vital to try to keep talented workers from Bristol-Myers Squibb in the state. The pharmaceutical company has announced it will shutter its Wallingford campus by the end of 2018.
A bipartisan mental health reform bill co-authored by Democratic Connecticut Senator Chris Murphy and Republican Louisiana Senator Bill Cassidy passed the Senate on Wednesday. It passed the House last week.
Naloxone is a lifesaving drug that can reverse the effects of an opioid overdose. Efforts have been made in the current opioid epidemic to make it more widely available, but the medication's rising price is complicating that.